Breast cancer screening in Germany - Changes are overdue;Brustkrebsfruherkennung in Deutschland. Zeit zum handeln

Radiologe

Volumn 40, Issue 2, 2000, Pages 177-183

  Engel, J ^a   Baumert, J ^a   Holzel D ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

Breast cancer; Quality assessment; Screening

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST EXAMINATION; CANCER MORTALITY; CANCER SCREENING; CONTROLLED STUDY; DIAGNOSTIC VALUE; FEMALE; GERMANY; HEALTH CARE COST; HEALTH CARE NEED; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; SCREENING TEST; BREAST TUMOR; CANCER STAGING; CAUSE OF DEATH; MASS SCREENING; MIDDLE AGED; MORTALITY; PATHOLOGY; PATIENT ATTITUDE; PRECANCER; STATISTICS; SURVIVAL RATE; UTILIZATION REVIEW;

BREAST NEOPLASMS; CAUSE OF DEATH; FEMALE; GERMANY; HUMANS; MAMMOGRAPHY; MASS SCREENING; MIDDLE AGED; NEOPLASM STAGING; PATIENT ACCEPTANCE OF HEALTH CARE; PRECANCEROUS CONDITIONS; SURVIVAL RATE;

EID: 0034073820     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001170050029     Document Type: Article

References (27)

1. Alexander FE, Anderson TJ, Brown HK, Forrest APM, Hepburn W, Kirkpatrick AE, Muir BB, Prescott RJ, Smith A (1999) 14 years of follow-up from the Edinburgh randomised trial of breast-cancer screening. Lancet 353:1903-1908
2. Boer R, Koning H de, Threlfall A et al. (1998) Cost effectiveness of shortening screening intervall or extending age range of NHS breast screening programme: computer simulation study. BMJ 317:376
3. Elmore JG, Barton MB, Moceri VM et al. (1998) Ten-year risk of false positive screening mammograms and clinical breast examination. N Engl J Med 338:1089-1096
4. Engel J, Schmidt M, Scheichenzuber J et al. (1998) Population-based patient care study for breast cancer. Onkologie 21:168-173
5. EU (1996) European Guidelines for quality assurance in mammography screening, 2nd ed. EU, Brussel
6. Fletcher SW (1997) Whither scientific deliberation in health policy recommendation. N Engl J Med 336:1180
7. Frischbier H, Hoeffken W, Robra B (1994) Mammographie in der Krebsfrüherkennung - Qualitätssicherung und Akzeptanz. Enke, Stuttgart
8. Fournier D (1997) Kosten-Nutzen-Analyse beim Mammographie-Screening. Forum DKG 12:625-630
9. Hakama M, Pukkala E, Heikkilä M, Kallio M (1997) Effectiveness of the public health policy for breast cancer screening in Finland: population based cohort study. BMJ 314:864-867
10. Hölzel D (1997) Krebsvorsorge am Scheideweg - Stagnation oder Reform. Frankfurter Allgem Z 12.2.1997
11. Hölzel D (1998) 25 Jahre Krebsfrüherkennung in Deutschland ohne Erfolgsbeurteilung. Forum DKG 13:532-540
12. Karsa L (1997) Einführung der Mammographie in das gesetzliche Krebsfrüherkennungsprogramm - Stand der Vorbereitungen. Forum DKG 12:631-635
13. Karsa L, Lang A, Flatten G (1993) Krankheitsfrüherkennung Krebs: Männer und Frauen. Zl für die kassenärztliche Versorgung. Deutscher Ärzteverlag, Köln
14. Kerlikowskw K, Grady D, Rubin S et al. (1995) Efficacy of screening mammography -a meta-analysis. JAMA 273:149-154
15. Lacour A, Mamelle N, Arnold F et al. (1997) Mass screening programs for breast cancer in France - average values of assessment criteria. Cancer Detect Prev 21:221-230
16. Lindfors KK, Rosenquist J (1995) The cost-effectiveness of mammographic screening strategies. JAMA 274:881-884
17. Miller AB, Baines CJ, To T, Wall C (1992) Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years. Can Med Assoc J 147:1477-1488
18. NIH consensus statement (1997) Breast cancer screening for women ages 40-49 January 21-23, 1997. J Natl Cancer Inst 89:1015-1026
19. Peto R (1998) Mortality from breast cancer in UK has decreased suddenly. BMJ 317:476-477
20. Quinn M, Allen E (1995) Changes in incidence of and mortality from breast cancer in England and Wales since introduction of screening. BMJ 311:1391-1395
21. Sox HC (1998) Benefit and harm associated with screening for breast cancer. N Engl J Med 338:1145-1146
22. Statistisches Bundesamt (1997) Todesursachen in Deutschland. Fachserie 12, Reihe 4. Metzler Poeschel, Stuttgart (erscheint jährlich)
23. Tabar L, Faberberg G, Day NE Holmberg L (1987) What is the optimum interval between mammographic screening examinations? Br J Cancer 55:547-551
24. Wells J (1998) Mammography and the politics of randomised controlled trials. BMJ 317:1224
25. Wright CJ, Mueller CB (1995) Screening mammography and public health policy: the need for perspective. Lancet 346:29-32
26. Woodman CBJ, Threlfail AG, Boggis CR, Prior P (1995) Is the three year breast screening interval too long? Occurence of interval cancer in NHS breast screening programme's north western region. BMJ 310:324-326
27. Zentralinstitut für die kassenärztliche Versorgung (1998) Förderung von Modellprojekten zur Erprobung des qualitätsgesicherten Mammographie-Screenings in der Bundesrepublik Deutschland. Dtsch Arztebl 95:A-2720